-
-
-
-
-
-
-
UBS Reiterates Buy Rating on CG Oncology (CGON) as AUA 2026 Abstracts Released
-
-
-
-
-
-
-
CG Oncology (CGON) PT Raised to $80 at H.C. Wainwright
-
-
-
-
-
-
-
Truist Securities Starts CG Oncology (CGON) at Buy
-
-
-
-
-
-
-
Jones Trading Starts CG Oncology (CGON) at Buy, PT $50
-
-
-
-
-
-
-
Goldman Sachs Resumes CG Oncology (CGON) at Buy
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c
-
435,198 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

